Jonathan Ross Goodman - Net Worth and Insider Trading
Jonathan Ross Goodman Net Worth
The estimated net worth of Jonathan Ross Goodman is at least $5 Million dollars as of 2024-12-26. Jonathan Ross Goodman is the Director, Director or Senior Officer of 10% Securi of Knight Therapeutics Inc and owns about 958,371 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $5 Million. Details can be seen in Jonathan Ross Goodman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan Ross Goodman has not made any transactions after 2024-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jonathan Ross Goodman
Jonathan Ross Goodman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan Ross Goodman owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Jonathan Ross Goodman’s form 4 insider trades.
Insider Ownership Summary of Jonathan Ross Goodman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2024-06-05 | Director & Director or Senior Officer of 10% Security Holder |
Jonathan Ross Goodman Latest Holdings Summary
Jonathan Ross Goodman currently owns a total of 1 stock. Jonathan Ross Goodman owns 958,371 shares of Knight Therapeutics Inc (TSX:GUD) as of June 5, 2024, with a value of $5 Million.
Latest Holdings of Jonathan Ross Goodman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2024-06-05 | 958,371 | 5.25 | 5,031,448 |
Holding Weightings of Jonathan Ross Goodman
Jonathan Ross Goodman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan Ross Goodman has made a total of 35 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years, including 35 buys and 0 sells. The most-recent trade in Knight Therapeutics Inc is the acquisition of 5,000 shares on June 5, 2024, which cost Jonathan Ross Goodman around $29,000.
Insider Trading History of Jonathan Ross Goodman
- 1
Jonathan Ross Goodman Trading Performance
GuruFocus tracks the stock performance after each of Jonathan Ross Goodman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan Ross Goodman is 1.72%. GuruFocus also compares Jonathan Ross Goodman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan Ross Goodman within 3 months outperforms 20 times out of 51 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan Ross Goodman's insider trading performs compared to the benchmark.
Performance of Jonathan Ross Goodman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.44 | | | | | |
| Relative Return to S&P 500(%) | -1.17 | | | | | |
Jonathan Ross Goodman Ownership Network
Jonathan Ross Goodman Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Jonathan Ross Goodman is the Director & Director or Senior Officer of 10% Security Holder of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include 10% Security Holder Sime Armoyan , Director & Senior Officer Samira Sakhia , and Senior Officer Amal Khouri .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Jonathan Ross Goodman made 2 insider transaction in Knight Therapeutics Inc (TSX:GUD) with a net purchase of 30,000. Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 774,800 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 0 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 120,000 shares, with a net purchase of 120,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,029,000 shares were bought by its insiders, resulting in a net purchase of 714,800 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Jonathan Ross Goodman Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan Ross Goodman. Currently GuruFocus does not have mailing address information for Jonathan Ross Goodman.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
